• Repurpose or Innovate: Sustained release changes everything

    TheraKine is partnering with global biopharmaceutical companies

  • Take control  with sustained release injectable formulations

    TheraKine is partnering with global biopharmaceutical companies

  • Life cycle management with significant performance advantages

    TheraKine is partnering with global biopharmaceutical companies

  • Organ-specific formulations? We do that!

    TheraKine is partnering with global biopharmaceutical companies

  • Local sustained delivery for your drug

    TheraKine is partnering with global biopharmaceutical companies

  • Become BIOBETTER with TheraKine

    TheraKine is partnering with global biopharmaceutical companies

TheraKine Limited is a privately held drug delivery Company

History of TheraKineCONTACT US

The first three years of the company were used to establish conceptual feasibility, first in the lab and then in simple animal trials. External validation of bioavailability with long-release formulations of human and animal antibodies demonstrated that it was possible to enable many months of linear release of biologic drugs. These results were used to raise funds, hire Dr. Andreas Voigt as Chief Scientist and open a lab in Berlin, and hire staff. Over the next two years TheraKine developed its patented technologies and performed in-vitro and in-vivo experiments to demonstrate tolerability, safety, and release kinetics.

In 2012 the US Air Force began animal trials of a topical formulation, additional patents were filed ensuring that the company had protection for the novel aspects of formulation and processing, and the results of a canine trial hinted at efficacy for an intra-vitreal injectable form.

In 2013 the company completed confidential feasibility trials with biopharmaceutical companies, and expanded the laboratory to support the commercialization of various products in the pipeline.  In 2014,  Seth Yakatan assumed the role of CEO, to drive partnering and commercialization of TheraKine's technologies.

TheraKine continues to expand its capabilities, file additional patents, and develop commercial technologies with current and new partners.